IL17A and vitiligo: Interestingly, this high number of IL-17-positive cells detected in immunotherapy-induced vitiligo lesions may suggest the recruitment of Th17 cells in situ, according to the decrease of circulating Th17 cells observed over treatment in this patient population (Figure 1).